Form HLTH5814 Special Authority Request - Edaravone (Oral Suspension and Intravenous Solution) for Amyotrophic Lateral Sclerosis (Als) - British Columbia, Canada

Form HLTH5814 Special Authority Request - Edaravone (Oral Suspension and Intravenous Solution) for Amyotrophic Lateral Sclerosis (Als) - British Columbia, Canada

ADVERTISEMENT

Other Revision

Download Form HLTH5814 Special Authority Request - Edaravone (Oral Suspension and Intravenous Solution) for Amyotrophic Lateral Sclerosis (Als) - British Columbia, Canada

4.6 of 5 (29 votes)
  • Form HLTH5814 Special Authority Request - Edaravone (Oral Suspension and Intravenous Solution) for Amyotrophic Lateral Sclerosis (Als) - British Columbia, Canada

    1

  • Form HLTH5814 Special Authority Request - Edaravone (Oral Suspension and Intravenous Solution) for Amyotrophic Lateral Sclerosis (Als) - British Columbia, Canada, Page 2

    2

  • Form HLTH5814 Special Authority Request - Edaravone (Oral Suspension and Intravenous Solution) for Amyotrophic Lateral Sclerosis (Als) - British Columbia, Canada, Page 1
  • Form HLTH5814 Special Authority Request - Edaravone (Oral Suspension and Intravenous Solution) for Amyotrophic Lateral Sclerosis (Als) - British Columbia, Canada, Page 2
Prev 1 2 Next
ADVERTISEMENT